K2VC's Biotechnology Portfolio

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

GluBio Therapeutics engages in molecular glue-targeted protein degradation drug discovery.

Fortitude Biomedicines is a biotechnology company that develops antibody-based biologic drugs targeting autoimmune diseases.

Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.

Yaotang Bio is a biotechnology company focusing on combining LNP delivery and gene editing technology.

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases

CirCode Bio is an innovative biotechnology company focusing on the development of circular RNA nucleic acid drugs.

Tinglan Urethane focuses on the research and development of novel materials and cross-field applications.

Renjing Biotech is engaged in the research and development of drugs based on messenger ribonucleic acid.

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

Exegenesis Bio is a Gene therapy start-up.